Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00853
Species: Homo sapiens
Position : chr13:42940000-42940969
Year: 2018
Title: Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: osteoporosis
PMID:  29528523
MONDO: MONDO:0005298
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: GM12878
CVCL ID: CVCL_7526
Cell Type: B-lymphoblastoid cell
Experiment Type: GWAS/eQTL integration; enhancer activity; chromatin interaction; endogenous perturbation
High Throughput Method: GWAS/eQTL; Hi-C; epigenomic annotation; RNA-seq/ChIP-seq integration; eQTL analysis
Low Throughput Method: Dual-luciferase reporter assay; CRISPR-Cas9 deletion of rs9533090 region; ChIP-qPCR; qRT-PCR; protein analysis; CRISPR-Cas9; Luciferase reporter assay
About Target Gene
Target gene : TNFSF11
About TF
TF name : NFIC
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
NFIC FOXA1 transcription factor network pid 45
NFIC p75(NTR)-mediated signaling pid 74
NFIC RNA Polymerase III Abortive And Retractive Initiation reactome 41
NFIC RNA Polymerase III Transcription Termination reactome 23
Enhancer Associated Network
Overlapping Enhancers (hg19) 4 found
Enhancer ID Position Tissue Cell Disease
E_00871 chr13:42939000-42967000 bone marrow hematopoietic stem/progenitor cell osteoporosis
E_00872 chr13:42939000-42967000 blood B-lymphoblastoid cell osteoporosis
E_00873 chr13:42939000-42967000 bone osteosarcoma-derived osteoblast-like cell osteoporosis
E_00858 chr13:42940000-42940969 bone osteosarcoma-derived osteoblast-like cell osteoporosis
Expression of Target Genes for the Enhancer